4//SEC Filing
Parini Michael 4
Accession 0001209191-21-008132
CIK 0000875320other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:52 PM ET
Size
17.6 KB
Accession
0001209191-21-008132
Insider Transaction Report
Form 4
Parini Michael
EVP & CLO
Transactions
- Award
Common Stock
2021-02-03+8,438→ 35,276 total - Award
Common Stock
2021-02-03+10,324→ 45,600 total - Sale
Common Stock
2021-02-03$215.52/sh−200$43,104→ 57,427 total - Sale
Common Stock
2021-02-03$218.20/sh−100$21,820→ 57,227 total - Award
Common Stock
2021-02-03+11,627→ 57,227 total - Exercise/Conversion
Common Stock
2021-02-03$86.52/sh+400$34,608→ 57,627 total - Sale
Common Stock
2021-02-03$217.00/sh−100$21,700→ 57,327 total - Exercise/Conversion
Stock Option (Right to buy)
2021-02-03−400→ 1,930 totalExercise: $86.52Exp: 2027-02-02→ Common Stock (400 underlying)
Footnotes (7)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021.
- [F2]Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021.
- [F3]Restricted stock unit award that vests in installments beginning on 02/17/2022.
- [F4]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- [F5]Open market sales reported on this line occurred at a weighted average price of $215.52 (range $215.47 to $215.58).
- [F6]Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F7]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001661567
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:52 PM ET
- Size
- 17.6 KB